These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 5961181)

  • 21. Sjögren's syndrome in seronegative spondyloarthropathies: an unusual finding.
    Gusis SE; Villa NG; Maldonado Cocco JA; Barceló HA; Scheines EJ; Catoggio LJ; Moreno C; Ravaglia C; Palioni J
    J Rheumatol; 1994 Apr; 21(4):771-2. PubMed ID: 8035411
    [No Abstract]   [Full Text] [Related]  

  • 22. [Preliminary study on the activity of natural killer cells in patients with Sjogren's syndrome].
    Wang JM
    Zhonghua Kou Qiang Yi Xue Za Zhi; 1988 Jul; 23(4):244-6. PubMed ID: 3234131
    [No Abstract]   [Full Text] [Related]  

  • 23. Sex differences in primary Sjögren's syndrome.
    Brennan MT; Fox PC
    J Rheumatol; 1999 Nov; 26(11):2373-6. PubMed ID: 10555894
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of T-cell large granular lymphocyte leukemia associated with Sjogren's syndrome-an important but under-recognized association.
    Friedman J; Schattner A; Shvidel L; Berrebi A
    Semin Arthritis Rheum; 2006 Apr; 35(5):306-11. PubMed ID: 16616153
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pulmonary disorders associated with Sjögren's syndrome.
    Fairfax AJ; Haslam PL; Pavia D; Sheahan NF; Bateman JR; Agnew JE; Clarke SW; Turner-Warwick M
    Q J Med; 1981; 50(199):279-95. PubMed ID: 7330166
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased levels of interleukin-10 in saliva of Sjögren's syndrome patients. Correlation with disease activity.
    Bertorello R; Cordone MP; Contini P; Rossi P; Indiveri F; Puppo F; Cordone G
    Clin Exp Med; 2004 Dec; 4(3):148-51. PubMed ID: 15599664
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of the immune status in patients with primary and secondary Sjögren's syndrome.
    Slezák R; Krejsek J; Kopecký O; Drízhal I
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1995; 38(1):11-2. PubMed ID: 7569721
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunogenetic studies of Sjögren's syndrome.
    Nakao Y; Fujita T; Yamauchi Y; Ishikawa H; Hirohata K; Miyawaki S; Suginoshita T; Matsumoto H; Tsuji K
    Ryumachi; 1981; 21 Suppl():135-40. PubMed ID: 7344123
    [No Abstract]   [Full Text] [Related]  

  • 29. Detection of cleaved alpha-fodrin autoantigen in Sjögren's syndrome: apoptosis and co-localisation of cleaved alpha-fodrin with activated caspase-3 and cleaved poly(ADP-ribose) polymerase (PARP) in labial salivary glands.
    Wang Y; Virji AS; Howard P; Sayani Y; Zhang J; Achu P; McArthur C
    Arch Oral Biol; 2006 Jul; 51(7):558-66. PubMed ID: 16405863
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Humoral and cellular immune responses to secretory IgA in Sjögren's syndrome (author's transl)].
    Ichikawa Y; Takaya M; Arimori S
    Ryumachi; 1980 Nov; 20(5):338-43. PubMed ID: 7345652
    [No Abstract]   [Full Text] [Related]  

  • 31. Lateral medullary syndrome with anti-neuronal antibodies (anti-Ta/Ma2) in primary Sjogren's syndrome.
    Mehta P; Fernando MM; Pickering MC; Wilson Y; Molloy S; Colaco CB
    Rheumatology (Oxford); 2009 Sep; 48(9):1174-6. PubMed ID: 19620208
    [No Abstract]   [Full Text] [Related]  

  • 32. [Etiopathogenic aspects of Sjögren's syndrome].
    Palomino Nicas J; Villar Ortiz J; Viciana Fernández P; Piedra Priego J; Carneado de la Fuente J
    Rev Clin Esp; 1984 Jun 15-30; 173(5-6):253-8. PubMed ID: 6387825
    [No Abstract]   [Full Text] [Related]  

  • 33. Diminished cellular immune response to carbonic anhydrase II in patients with Sjögren's syndrome and idiopathic chronic pancreatitis.
    Nishimori I; Miyaji E; Morimoto K; Kohsaki T; Okamoto N; Onishi S
    JOP; 2004 Jul; 5(4):186-92. PubMed ID: 15254347
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Sjögren's disease].
    Bijl M; Panders AK; Vissink A; Nikkels PG; Kallenberg CG
    Ned Tijdschr Geneeskd; 1994 May; 138(21):1049-52. PubMed ID: 8202174
    [No Abstract]   [Full Text] [Related]  

  • 35. Antifodrin antibodies in Sjogren's syndrome: a review.
    Witte T
    Ann N Y Acad Sci; 2005 Jun; 1051():235-9. PubMed ID: 16126964
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Immunohistological studies on T lymphocyte subsets of the salivary glands in Sjögren's syndrome].
    Takaya M; Ichikawa Y; Koriyama K; Shimizu H; Arimori S
    Ryumachi; 1984 Aug; 24(4):250-5. PubMed ID: 6334896
    [No Abstract]   [Full Text] [Related]  

  • 37. [Hepatological aspects of Sjögren's disease and syndrome].
    Tareev EM; Aprosina ZG; Serov VV; Lopatkina TN; Popova IV
    Ter Arkh; 1982; 54(12):38-44. PubMed ID: 7157181
    [No Abstract]   [Full Text] [Related]  

  • 38. Ulcerative colitis and Sjogren's syndrome in the same patient: report of two cases and a review of the literature.
    Triantafillidis JK; Roussou P; Manousos ON; Dadioti P; Nicolakis D
    Ital J Gastroenterol; 1994; 26(6):299-302. PubMed ID: 7949267
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Studies on killer cells (K-cells) in peripheral blood in Sjögren's syndrome (author's transl)].
    Ichikawa Y; Sasao K; Takaya M; Arimori S
    Ryumachi; 1980 Sep; 20(4):253-9. PubMed ID: 7444663
    [No Abstract]   [Full Text] [Related]  

  • 40. [Clinical aspects of Sjögren's syndrome].
    Ofuji T
    Ryumachi; 1983 Feb; 23(1):50-8. PubMed ID: 6867870
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.